Patrick Dolezal

Stock Analyst at LifeSci Capital

(2.75)

# 1,732

Out of 5,182 analysts

2

Total ratings

100%

Success rate

72.39%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Patrick Dolezal

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NGNE Neurogene	Initiates: Outperform	$50	$23.97	+108.59%	1	Jan 26, 2026
	KOD Kodiak Sciences	Initiates: Outperform	$40	$40.60	-1.48%	1	Oct 23, 2025

Neurogene

Jan 26, 2026

Initiates: Outperform

Price Target: $50

Current: $23.97

Upside: +108.59%

Kodiak Sciences

Oct 23, 2025

Initiates: Outperform

Price Target: $40

Current: $40.60

Upside: -1.48%